The epigenome as a therapeutic target in prostate cancer.
Title:
The epigenome as a therapeutic target in prostate cancer.
Journal:
Targeted Proteins Database
Publication Id:
21701
Volume:
1
Number:
158
year:
2008
Status:
published More like this
- In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.
- Urinary markers for prostate cancer.
- The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkers.
- Discovery of DNA hypermethylation using a DHPLC screening strategy.
- 2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer.